| Literature DB >> 24192912 |
Rupesh Nanjunda1, Eric A Owens, Leah Mickelson, Tyler L Dost, Ekaterina M Stroeva, Hang T Huynh, Markus W Germann, Maged M Henary, W David Wilson.
Abstract
A variety of cyanines provide versatile and sensitive agents acting as DNA stains and sensors and have been structurally modified to bind in the DNA minor groove in a sequence dependent manner. Similarly, we are developing a new set ofEntities:
Mesh:
Substances:
Year: 2013 PMID: 24192912 PMCID: PMC4457452 DOI: 10.3390/molecules181113588
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Trimethine cyanine analogs used in the current study. The modifications performed on the parent cyanine (24) are highlighted in different colors (compounds 25–32). The detailed synthetic procedure is described in Section 4.1. All compounds have one positive charge on the cyanine system and most have charged alkyl amine substituents. The synthesis and characterization of the related pentamethine cyanine analogs (compounds 1–23) are previously reported [18].
Tm changes of trimethine cyanine analogs with telomeric quadruplex (Tel22) and a control duplex (AATT).
| Compound/Drug:DNA Ratio | Tel22 | AATT duplex | ||||||
|---|---|---|---|---|---|---|---|---|
| 1:1 | 2:1 | 4:1 | 6:1 | 1:1 | 2:1 | 4:1 | 6:1 | |
|
| 2 | 4 | 9 | 14 | 0 | 1 | 1 | 2 |
|
| - | 2.1 | 4.6 | 8.7 | 0 | 0 | 0 | 0 |
|
| 1 | 1 | 1 | 0 | ND | |||
|
| 1 | 2 | 4 | 11 | 0 | 2 | 2 | 2 |
|
| 2 | 1 | 1 | 1 | ND | |||
|
| 1 | 1 | 3 | 7 | 1 | 1 | 2 | 3 |
|
| 3 | 8 | 12 | 16 | 0 | 1 | 1 | 2 |
|
| 3 | 7 | 15 | 19 | 0 | 0 | 1 | 1 |
|
| - | 3.1 | 8.9 | 13.2 | 0 | 0 | 0 | 0.5 |
|
| 1 | 5 | 14 | 24 | 0 | 0 | 0 | 0 |
|
| - | 2.5 | 15.6 | - | 0 | 0 | 0 | 1.1 |
|
| 3 | 7 | 17 | 21 | 1 | 1 | 3 | 3 |
The thermal melting values reported are an average of two independent trials and are reproducible within ±0.5 °C. Tm values of free Tel22 and AATT are 61 °C and 66 °C respectively. ND = Not Determined. a, b, c: ∆Tm values from previous studies for pentamethine analogs with the substitutions for a: X = H; b: X = Cl; c: X = Br and R = TMAB in all cases [18].
Figure 2SPR sensorgrams and the steady-state binding plots for the parent cyanine (24, panel a) and the brominated analog (31, panel b) with Tel22 and cMYC19 quadruplexes and a control duplex (AATT). The injected concentration range for 24 is 10 nM–10 µM and for 31 is 10 nM–1 µM. The binding plots were obtained by fitting the steady-state response values (RU) as a function of free ligand concentration (Cfree) and fit to a two-site binding model. The estimated equilibrium binding affinities (K1 and K2) are reported in Table 2.
Equilibrium binding constants of the trimethine cyanine analogs with Tel22 and cMYC19 quadruplex sequences obtained from SPR studies.
| Compound | Tel22 ( | cMYC19 ( | AATT ( |
|---|---|---|---|
|
| 3.9 × 105; 3.9 × 104 | 3.8 × 106; 1.4 × 105 | <105 |
|
| No Binding | No Binding | No Binding |
|
| 1.3 × 105; 1.7 × 104 | 1.2 × 106; 6.6 × 105 | <105 |
|
| 8.2 × 105; 5.8 × 104 | 5.7 × 105; 4.5 × 104 | <105 |
|
| 8.3 × 105; 6.1 × 104 | 5.0 × 106; 5.6 × 105 | <105 |
|
| 5.9 × 106; 3.9 × 105 | 6.3 × 106; 4.3 × 105 | <105 |
|
| 2.7 × 106; 2.9 × 105 | 8.4 × 106; 3.3 × 105 | <105 |
|
| 5.5 × 106; 4.5 × 105 | 1.2 × 107; 2.7 × 106 | <105 |
|
| 2.1 × 106; 2.2 × 105 | 7.8 × 106; 2.5 × 106 | <105 |
The steady-state response obtained as a function of free ligand concentration was fitted to a two-site binding model to obtain K1 and K2 values. The binding constant values are reproducible with ±10%. No Binding: No sensorgrams were observed in the concentration range that was tested. In all cases, no significant duplex binding was observed suggesting a high selectivity of the ligands for quadruplexes.
Figure 3CD spectra of the parent cyanine (24, panel a) and the brominated analog (31, panel b) with Tel22 and cMYC19 quadruplex sequences. The ligands were titrated into the quadruplex solutions (5 µM) until no further change in ICD signals were obtained. The insets show the mole ratio of drug:DNA.
Figure 4Imino proton spectra of MYC22 quadruplex titrated with the parent cyanine 24 (a) and the brominated analogue 31 (b). Ligands were added to the quadruplex at the ratio indicated on the plot. Selected imino protons of 3ʹ-end (9, red) middle (8, blue) and 5ʹ-end (16, green) tetrads are marked.
Figure 5(a) Schematic structure of the c-myc quadruplex MYC22 adopted from [30]. For clarity the imino protons of the guanine tetrads are color coded. Red: 3ʹ-end tetrad, blue: center tetrad, and green: 5ʹ-end tetrad. Imino proton titration curves of 3ʹ-end, middle and 5ʹ-end tetrad for the parent cyanine (24, b) and the brominated analog (31, c).
Figure 6Fluorescence emission spectra of the parent cyanine (24, panel a) and the brominated analog (31, panel b) with Tel22 and cMYC19 quadruplex sequences. The arrow indicates increasing concentrations of DNA titrated into the ligand solution (1 µM) until no further change in the fluorescence emission signal was detected.